Atlas Trials

Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study

Clinical trial NCT04047602 · TERMINATED

Trial details

NCT number
NCT04047602
Sponsor
Indiana University
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Brain TumorBrain MetastasesBrain Cancer
Start date
2019-12-12
Primary completion
2023-07-25
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.